Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.22.38 extracted from

  • Thomson, S.K.; Halbert, S.M.; Bossard, M.J.; Tomaszek, T.A.; Levy, M.A.; Zhao, B.; Smith, W.W.; Abdel- Meguid, S.S.; Janson, C.A.; D'Alessio, K.J.; McQueney, M.S.; Amegadzie, B.Y.; Hanning, C.R.; DesJarlais, R.L.; Briand, J.; Sakkar, S.K.; Huddleston, M.J.; Ijames, C.F.; Carr, S.A; Garnes, K.T.; Shu, A.; Heys, J.R.; Bradbeer, J.; Zembryki, D.; Lee-Rykyczewski, L.; James, I.E.; Lark, M.W.; Drake, F.H.; Gowen, M.; Gleason, J.G.; Veber, D.F.
    Design of potent and selective human cathepsin K inhibitors that span the active site (1997), Proc. Natl. Acad. Sci. USA, 94, 1429-1454.
No PubMed abstract available

Crystallization (Commentary)

Crystallization (Comment) Organism
complexed with synthetic inhibitors Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
Synthetic inhibitors
-
Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-